Global News | World latest News| Trending News
Newswise — Boston – Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine. The vaccines were administered after surgery to remove…
RESEARCH SUMMARY Newswise — Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study Publication: The Lancet Oncology – January 2025 Dana-Farber Cancer Institute authors: Toni K. Choueiri, MD Summary: In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute’s…
Newswise — Members of the Department of Urology at Hackensack University Medical Center have launched the Kidney Cancer Resource Center, an online educational tool for people diagnosed with renal cell carcinoma, a type of kidney cancer. The website provides information to help them better understand the disease and make treatment decisions based on the findings…
STONY BROOK, NY, January 7, 2025 – Fighting off infections when one has chronic disease is a common problem, and during the Covid-19 pandemic that scenario often turned out to be dangerous and deadly. A new study led by Stony Brook Medicine demonstrates that advanced kidney disease compromises the survival of B cells, a type…
BACKGROUND Newswise — To date, no specific treatment has been established to reverse progressive chronic kidney disease (CKD). AIM To evaluate the safety and efficacy of autologous CD34+ cell transplantation in CKD patients who exhibited a progressive decline in renal function. METHODS The estimated glomerular filtration rate (eGFR) at the beginning of the study was…
Newswise — Washington, DC (December 17, 2024) —The American Society of Nephrology (ASN) commends Senator John Boozman and Senator Ben Ray Luján for their introduction of the Honor Our Living Donors (HOLD) Act in the Senate. “No living donor should face out of pocket costs for giving the gift of life,” said ASN President Deidra…
Newswise — Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating that the urinary tract is not sterile and low levels of bacteria are normal. The Nature Communications publication describes the rigorous multi-pronged approach a team led by Aaron Miller, PhD, and José Agudelo, MD, used to identify and characterize…
Newswise — WASHINGTON, DC (December 4, 2024)—The American Society of Nephrology (ASN) celebrates the introduction of the Expanding Support for Living Donors Act of 2024, legislation that would bolster and expand support for living organ donors. “Donating a life-saving organ is one of the greatest possible gifts. ASN believes that living donation should be a…
